Pi, H.; Ogunniyi, A.D.; Savaliya, B.; Nguyen, H.T.; Page, S.W.; Lacey, E.; Venter, H.; Trott, D.J.
Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci. Microorganisms 2021, 9, 1697.
https://doi.org/10.3390/microorganisms9081697
AMA Style
Pi H, Ogunniyi AD, Savaliya B, Nguyen HT, Page SW, Lacey E, Venter H, Trott DJ.
Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci. Microorganisms. 2021; 9(8):1697.
https://doi.org/10.3390/microorganisms9081697
Chicago/Turabian Style
Pi, Hongfei, Abiodun D. Ogunniyi, Bhumi Savaliya, Hang Thi Nguyen, Stephen W. Page, Ernest Lacey, Henrietta Venter, and Darren J. Trott.
2021. "Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci" Microorganisms 9, no. 8: 1697.
https://doi.org/10.3390/microorganisms9081697
APA Style
Pi, H., Ogunniyi, A. D., Savaliya, B., Nguyen, H. T., Page, S. W., Lacey, E., Venter, H., & Trott, D. J.
(2021). Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci. Microorganisms, 9(8), 1697.
https://doi.org/10.3390/microorganisms9081697